文献
J-GLOBAL ID:202002285741976635
整理番号:20A2755231
新規の非常に強力な腫瘍壊死因子(TNF)関連アポトーシス誘導リガンド(TRAIL)受容体2アゴニスト,MEDI3039は正所性腫瘍を退縮し,転移性トリプルネガティブ乳癌の成長を阻害する【JST・京大機械翻訳】
MEDI3039, a novel highly potent tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptor 2 agonist, causes regression of orthotopic tumors and inhibits outgrowth of metastatic triple-negative breast cancer
著者 (8件):
Greer Yoshimi Endo
(Women’s Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, USA)
,
Gilbert Samuel F.
(Women’s Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, USA)
,
Gril Brunilde
(Women’s Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, USA)
,
Narwal Rajesh
(MedImmune, LLC, Gaithersburg, USA)
,
Brooks Danielle L. Peacock
(Women’s Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, USA)
,
Tice David A.
(MedImmune, LLC, Gaithersburg, USA)
,
Steeg Patricia S.
(Women’s Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, USA)
,
Lipkowitz Stanley
(Women’s Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, USA)
資料名:
Breast Cancer Research (Web)
(Breast Cancer Research (Web))
巻:
21
号:
1
ページ:
1-17
発行年:
2019年
JST資料番号:
U7313A
ISSN:
1465-542X
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
イギリス (GBR)
言語:
英語 (EN)